Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Beijing Percutaneous Coronary Intervention Registry (BJPCI Registry)

This study is currently recruiting participants. (see Contacts and Locations)
Verified September 2011 by Cardiovascular Institute & Fuwai Hospital
Information provided by (Responsible Party):
Yang yuejin, Cardiovascular Institute & Fuwai Hospital Identifier:
First received: August 15, 2011
Last updated: September 16, 2011
Last verified: September 2011

The registry study is to obtain the state of the art of the percutaneous coronary intervention state treatment for coronary heart disease in Beijing area of P.R.China in a real world. The data are collected from 48 hospitals in Beijing area using an uploading system through internet.

Coronary Heart Disease

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Cross-Sectional
Official Title: A Registry Study of Percutaneous Coronary Intervention Treatment in Beijing Area of P.R. China

Resource links provided by NLM:

Further study details as provided by Cardiovascular Institute & Fuwai Hospital:

Estimated Enrollment: 700000
Study Start Date: January 2010
Estimated Study Completion Date: December 2020
Estimated Primary Completion Date: December 2020 (Final data collection date for primary outcome measure)

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

All the patients receiving coronal artery angiography or percutaneous coronary intervention therapy in selected 48 hospitals of Beijing, P.R.China.


Inclusion Criteria:

  • Patients from selected 48 hospitals of Beijing, P.R.China
  • Patients receiving coronal artery angiography or percutaneous coronary intervention therapy

Exclusion Criteria:

  • none
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01417325

Contact: Yuejin Yang, Doctor 8610-68314466
Contact: Lei Song, Doctor 8610-13910968125

China, Beijing
Beijing cardiovascular intervention quality control and improvement center Recruiting
Beijing, Beijing, China, 100037
Contact: Yuejin Yang, doctor    8610-88398800   
Contact: Lei Song, doctor    8610-13910968125   
Sponsors and Collaborators
Cardiovascular Institute & Fuwai Hospital
Study Chair: Yuejin Yang, doctor Fuwai Heart Hospital & Cardiovascular Institute
  More Information

No publications provided

Responsible Party: Yang yuejin, Director of coronary heart disease center, vice president of Fuwai hospital, Cardiovascular Institute & Fuwai Hospital Identifier: NCT01417325     History of Changes
Other Study ID Numbers: Bciqcic-fw-01
Study First Received: August 15, 2011
Last Updated: September 16, 2011
Health Authority: China: Food and Drug Administration

Additional relevant MeSH terms:
Coronary Artery Disease
Coronary Disease
Myocardial Ischemia
Arterial Occlusive Diseases
Cardiovascular Diseases
Heart Diseases
Vascular Diseases processed this record on March 03, 2015